دورية أكاديمية

A phase I feasibility study of multi-modality imaging assessing rapid expansion of marrow fat and decreased bone mineral density in cancer patients.

التفاصيل البيبلوغرافية
العنوان: A phase I feasibility study of multi-modality imaging assessing rapid expansion of marrow fat and decreased bone mineral density in cancer patients.
المؤلفون: Hui, Susanta K, Arentsen, Luke, Sueblinvong, Thanasak, Brown, Keenan, Bolan, Pat, Ghebre, Rahel G, Downs, Levi, Shanley, Ryan, Hansen, Karen E, Minenko, Anne G, Takhashi, Yutaka, Yagi, Masashi, Zhang, Yan, Geller, Melissa, Reynolds, Margaret, Lee, Chung K, Blaes, Anne H, Allen, Sharon, Zobel, Bruno Beomonte, Le, Chap, Froelich, Jerry, Rosen, Clifford, Yee, Douglas
المصدر: Maine Medical Center
بيانات النشر: MaineHealth Knowledge Connection
سنة النشر: 2015
المجموعة: MaineHealth Knowledge Connection
مصطلحات موضوعية: Absorptiometry, Photon, Adult, Aged, Bone Density, Bone Marrow, Fats, Feasibility Studies, Female, Humans, Middle Aged, Multimodal Imaging, Neoplasms, Tomography, X-Ray Computed, Medical Specialties, Medicine and Health Sciences, Musculoskeletal System, Oncology, Radiology
الوصف: PURPOSE: Cancer survivors are at an increased risk for fractures, but lack of effective and economical biomarkers limits quantitative assessments of marrow fat (MF), bone mineral density (BMD) and their relation in response to cytotoxic cancer treatment. We report dual energy CT (DECT) imaging, commonly used for cancer diagnosis, treatment and surveillance, as a novel biomarker of MF and BMD. METHODS: We validated DECT in pre-clinical and phase I clinical trials and verified with water-fat MRI (WF-MRI), quantitative CT (QCT) and dual-energy X-ray absorptiometry (DXA). Basis material composition framework was validated using water and small-chain alcohols simulating different components of bone marrow. Histologic validation was achieved by measuring percent adipocyte in the cadaver vertebrae and compared with DECT and WF-MRI. For a phase I trial, sixteen patients with gynecologic malignancies (treated with oophorectomy, radiotherapy or chemotherapy) underwent DECT, QCT, WF-MRI and DXA before and 12months after treatment. BMD and MF percent and distribution were quantified in the lumbar vertebrae and the right femoral neck. RESULTS: Measured precision (3mg/cm(3)) was sufficient to distinguish test solutions. Adiposity in cadaver bone histology was highly correlated with MF measured using DECT and WF-MRI (r=0.80 and 0.77, respectively). In the clinical trial, DECT showed high overall correlation (r=0.77, 95% CI: 0.69, 0.83) with WF-MRI. MF increased significantly after treatment (p CONCLUSION: Our study demonstrated that DECT, similar to WF-MRI, can accurately measure marrow adiposity. Both imaging modalities show rapid increase in MF following cancer treatment. Our results suggest that MF and BMD cannot be used interchangeably to monitor skeletal health following cancer therapy.
نوع الوثيقة: text
اللغة: unknown
العلاقة: https://knowledgeconnection.mainehealth.org/mmc/21Test; https://www.ncbi.nlm.nih.gov/pubmed/25536285Test
الإتاحة: https://knowledgeconnection.mainehealth.org/mmc/21Test
https://www.ncbi.nlm.nih.gov/pubmed/25536285Test
رقم الانضمام: edsbas.D13EFAB0
قاعدة البيانات: BASE